<DOC>
	<DOCNO>NCT00762229</DOCNO>
	<brief_summary>The purpose study compare effect LDL cholesterol level convert patient receive cholesterol absorption inhibitor Zetia dose 10 milligram 5 milligram , prescribe split 10 milligram tablet .</brief_summary>
	<brief_title>Evaluation LDL Cholesterol Patients Switched From 10 5 Milligrams Zetia ( Ezetimibe )</brief_title>
	<detailed_description />
	<mesh_term>Hypercholesterolemia</mesh_term>
	<mesh_term>Ezetimibe</mesh_term>
	<criteria>Subjects receive ezetimibe 10 mg Subjects demonstrate compliance ezetimibe evidence following Proportions Days Covered pattern ( represent PDC 75 % ) : 90 day prescription : Filled ezetimibe prescription within previous 4 month 60 day prescription : Filled ezetimibe prescription within previous 2.5 month 30 day prescription : Filled ezetimibe prescription within previous 1.5 month Patients willing able provide sign informed consent Patients receive ezetimibe Patients receive ezetimibe 5 milligrams Patients history titrate ezetimibe 5 10 mg. Stroke , TIA , myocardial infarction , unstable angina , percutaneous coronary intervention , coronary artery bypass surgery , major surgery within 3 month Cancer undergo active treatment Participation clinical study within last 30 day Drug addiction alcohol abuse within past 6 month Patients unwilling unable provide inform consent Patients poor compliance Women childbearing potential</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>June 2013</verification_date>
	<keyword>Cholesterol</keyword>
	<keyword>Ezetimibe</keyword>
</DOC>